Sayin, B., Dereli, B., Senol, Y. C., Akmangit, I., Karaman, A., Daglioglu, E., & Belen, A. D.
98%
Near complete-complete occlusion rate (OKM C-D) at 16.2 months
82%
Complete occlusion rate (OKM D) at 16.2 months
Number of patients | 41 |
Number of aneurysms | 52 |
Major morbidity and mortality | 0% |
In-stent stenosis (≥50%) | 0% |
Turkish Neurosurgery | 2023
Sayin, B., Dereli, B., Senol, Y. C., Akmangit, I., Karaman, A., Daglioglu, E., & Belen, A. D. (2023). The Evaluation of Low-Profile Surpass EvolveTM Flow Diverter for Endovascular Treatment of Distal Cerebral Artery Aneurysms: A Single-Center Experience. Turkish neurosurgery, 33(3), 477–487. https://doi.org/10.5137/1019-5149.JTN.42071-22.1
Stryker or its affiliated entities own, use, or have applied for the following trademarks or service marks: Stryker, Surpass Evolve. All other trademarks are trademarks of their respective owners or holders.
Information contained herein for use outside the US only.
AP004695 v1.0